CN1349795A - Compound slimming prepn and its application - Google Patents
Compound slimming prepn and its application Download PDFInfo
- Publication number
- CN1349795A CN1349795A CN 00117562 CN00117562A CN1349795A CN 1349795 A CN1349795 A CN 1349795A CN 00117562 CN00117562 CN 00117562 CN 00117562 A CN00117562 A CN 00117562A CN 1349795 A CN1349795 A CN 1349795A
- Authority
- CN
- China
- Prior art keywords
- human body
- body weight
- compound preparation
- carnitine
- losing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The compound preparation for reducing weight of human body is made up by compounding two dosage forms of soft capsule in which the conjugate linoleic acid is used as main component and hard capsule formed from L-carnitine, chromium pyridine formate and L-5-hydroxytryptophane. Said invented product is safe, has no side effect, and can obtain good weight-reducing effect.
Description
Conjugated linoleic acid and three kinds of diet food additives of the present invention relates to be formed by artificial refining refinement comprise the compound preparation that L-L-carnitine, chromium picolinate, L-5-oxitriptan are formed and are applied to human body weight-losing.It has the safety of height and does not have side reaction, and has compared more rational, significant fat-reducing effect with above-mentioned any single composition.
Conjugated linoleic acid (Conjugated linoleic acid writes a Chinese character in simplified form CLA) is the natural nutrient of just being familiar with recently, all has a spot of CLA in a lot of foods, as milk product and beef etc.Have hundreds of pieces of scientific papers and patent report CLA to have unique trophic function recently, only the scientific paper of the CLA health care of report in 1999 just reaches more than 120 piece.According to these scientific paper experimental studies result, CLA is the lipoprotein lipase inhibitor, can make human body utilization burning fat that energy is provided, and reduces lipidosis.CLA can help human body to recover the balance of fat and muscle effectively.The discovery of CLA is considered to over past ten years at the most great scientific advance of natural nutrition healthcare field.
Animal experiment is discovered, the CLA of mouse feeding 0.5%, and demonstration can make fat reduce 60%, and muscle increases by 14%.The human body double blind controling test that abroad carries out shows that body weight and the fat of taking the CLA group all can lower.
L-L-carnitine, chromium picolinate, L-5-oxitriptan are present internationally recognized food additive with certain effect of weight reducing.Wherein L-L-carnitine, L-5 oxitriptan are the human body composition, and chromium picolinate was food additive in 1994 by drugs approved by FDA.The L-L-carnitine is a kind of fat combustion accelerator, and it enters the mitochondrion decomposition by the enhancing fatty acid and works.Chromium picolinate can blood sugar regulation and blood fat.The L-5-oxitriptan works as neurotransmitter.
Purpose of the present invention, be to be that the mechanism that CLA, L-L-carnitine, chromium picolinate, L-5-oxitriptan participate in fat-reducing has nothing in common with each other and four kinds of fool proof characteristics that meet the requirement of food additive of composition according to above-mentioned four kinds of compositions, invention reaches the purposes that different fat-reducing mechanism are replenished Synergistic mutually based on the soft capsule of CLA with based on the compound formulation that two kinds of dosage form reprovisions of hard capsule of L-L-carnitine, chromium picolinate and L-5-oxitriptan form.
The compound preparation of forming with conjugated linoleic acid (500mg-5000mg/day) and L-L-carnitine (10mg-100mg/day), chromium picolinate (50 μ g-900 μ g/day), L-5-oxitriptan (15mg-500mg/day) is used for human body weight-losing.
The compound preparation that any composition is formed in the conjugated linoleic acid (500mg-5000mg/day) that forms with artificial refining refinement and L-L-carnitine (10mg-100mg/day), chromium picolinate (50 μ g-900 μ g/day), three kinds of compositions of L-5-oxitriptan (15mg-500mg/day) is used for human body weight-losing.
The conjugated linoleic acid employing is existing, purity is made soft capsule at the product more than 70%.That L-L-carnitine, chromium picolinate, L-5-oxitriptan adopt is existing, purity is made hard capsule at the product more than 95%.
Concrete, divide three groups to carry out human clinical's contrast test:
First group, use conjugated linoleic acid (CLA) soft capsule separately, three times on the one, take in half an hour ante cibum at every turn, obey the 1.5g soft capsule at every turn, wherein cla levels is greater than 70%.Took continuously two months, and had 20 people and participate in.
Second group, conjugated linoleic acid (CLA) soft capsule and L-L-carnitine hard capsule are taken simultaneously, three times on the one, take in half an hour ante cibum at every turn, the hard capsule of each clothes 1.5g soft capsule and 10mgL-L-carnitine, wherein the soft capsule cla levels was taken two months continuously greater than 70%, had 20 people and participated in.
The 3rd group, conjugated linoleic acid (CLA) soft capsule and take simultaneously by the hard capsule that L-L-carnitine, chromium picolinate, L-5-oxitriptan are formed, three times on the one, take in half an hour ante cibum at every turn, the hard capsule of each clothes 1.5g soft capsule and 10mgL-L-carnitine, 280 μ g chromium picolinates, 5mgL-5-oxitriptan, wherein soft capsule contains conjugated linoleic acid greater than 70%, takes continuously two months, has 20 people and participates in.
Select for use body weight Body Weight (BW) and two leading indicators of body fat percentage composition Body Fat% (BF%) to carry out statistical analysis, its result is as follows:
| Group number | Body weight (BW) | Body fat content (BF%) | ||
| Before the use | After the use | Before the use | After the use | |
| First group | ?62kg | ?61kg | ?22％ | ?17％ |
| Second group | ?64kg | ?63kg | ?23％ | ?18％ |
| The 3rd group | ?65kg | ?62kg | ?23％ | ?17％ |
Test shows that 60 none example of routine participant have side reaction.The above results shows that the 3rd group of compound preparation has the more significant effect of weight reducing that reduces fat and reduce body weight.
Claims (11)
1, a kind of compound preparation that is used for human body weight-losing is characterized in that by conjugated linoleic acid and have the food additive of certain effect of weight reducing formulated.
2, the compound preparation that is used for human body weight-losing according to claim 1 is characterized in that it is the L-L-carnitine that the food additive of certain effect of weight reducing is arranged.
3, the compound preparation that is used for human body weight-losing according to claim 1 is characterized in that it is chromium picolinate that the food additive of certain effect of weight reducing is arranged.
4, the compound preparation that is used for human body weight-losing according to claim 1 is characterized in that it is the L-5-oxitriptan that the food additive of certain effect of weight reducing is arranged.
5, the compound preparation that is used for human body weight-losing according to claim 1 is characterized in that the compound preparation that conjugated linoleic acid and L-L-carnitine, chromium picolinate, L-5-oxitriptan are formed is used for human body weight-losing.
6, the compound preparation that is used for human body weight-losing according to claim 1 is characterized in that the compound preparation that any composition is formed in conjugated linoleic acid and L-L-carnitine, chromium picolinate, three kinds of compositions of L-5-oxitriptan is used for human body weight-losing.
7, the compound preparation that is used for human body weight-losing according to claim 1, it is characterized in that the conjugated linoleic acid use amount is 500mg-5000mg/day, L-L-carnitine use amount is 10mg-100mg/day, the chromium picolinate use amount is 50 μ g-900 μ g/day, and L-5-oxitriptan use amount is 15mg-500mg/day.
8,, it is characterized in that conjugated linoleic acid (CLA) employing is existing, purity is made soft capsule at the product more than 70% according to claim 1 and the 7 described compound preparations that are used for human body weight-losing.
9, the compound preparation that is used for human body weight-losing according to claim 1 is characterized in that L-L-carnitine, chromium picolinate, L-5-oxitriptan adopt existing, purity to make hard capsule at the product more than 95%.
10, the compound preparation that is used for human body weight-losing according to claim 1, it is characterized in that application process is as follows: conjugated linoleic acid (CLA) soft capsule and L-L-carnitine hard capsule are taken simultaneously, three times on the one, take in half an hour ante cibum at every turn, the hard capsule of each clothes 1.5g soft capsule and 10mgL-L-carnitine, wherein the soft capsule cla levels is taken more than one month continuously greater than 70%.
11, the compound preparation that is used for human body weight-losing according to claim 1, it is characterized in that application process is as follows: conjugated linoleic acid (CLA) soft capsule and take simultaneously by the hard capsule that L-L-carnitine, chromium picolinate, L-5-oxitriptan are formed, three times on the one, take in half an hour ante cibum at every turn, the hard capsule of each clothes 1.5g soft capsule and 10mgL-L-carnitine, 280 μ g chromium picolinates, 5mg L-5-oxitriptan, wherein soft capsule contains conjugated linoleic acid greater than 70%, takes more than one month continuously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00117562 CN1349795A (en) | 2000-10-19 | 2000-10-19 | Compound slimming prepn and its application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00117562 CN1349795A (en) | 2000-10-19 | 2000-10-19 | Compound slimming prepn and its application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1349795A true CN1349795A (en) | 2002-05-22 |
Family
ID=4586922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00117562 Pending CN1349795A (en) | 2000-10-19 | 2000-10-19 | Compound slimming prepn and its application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1349795A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100361654C (en) * | 2004-12-15 | 2008-01-16 | 方云朝 | Body-building weight-reducing capsule and its preparation process |
| CN100446681C (en) * | 2005-06-23 | 2008-12-31 | 天津药业研究院有限公司 | Fat-weight-reducing food |
| CN100539999C (en) * | 2007-06-01 | 2009-09-16 | 中山市尤利卡天然药物有限公司 | Be used for fat-reducing, blood fat reducing, blood sugar lowering, blood pressure lowering, the osteoporotic compound preparation of control |
| CN101068918B (en) * | 2004-08-16 | 2010-05-26 | Pl生物株式会社 | Lactobacillus rhamnosus with body-fat reducing activity and the foods containing them |
| CN102188565A (en) * | 2011-04-09 | 2011-09-21 | 荣成百合生物技术有限公司 | Weight-losing soft capsules and preparation method thereof |
| CN105663912A (en) * | 2015-12-30 | 2016-06-15 | 韩俊峰 | Compound traditional Chinese medicine pill for reducing weight |
| CN107625914A (en) * | 2017-10-16 | 2018-01-26 | 唐宏泉 | A kind of cosmetic slimming nutrition and health care capsule and preparation method thereof |
-
2000
- 2000-10-19 CN CN 00117562 patent/CN1349795A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101068918B (en) * | 2004-08-16 | 2010-05-26 | Pl生物株式会社 | Lactobacillus rhamnosus with body-fat reducing activity and the foods containing them |
| CN100361654C (en) * | 2004-12-15 | 2008-01-16 | 方云朝 | Body-building weight-reducing capsule and its preparation process |
| CN100446681C (en) * | 2005-06-23 | 2008-12-31 | 天津药业研究院有限公司 | Fat-weight-reducing food |
| CN100539999C (en) * | 2007-06-01 | 2009-09-16 | 中山市尤利卡天然药物有限公司 | Be used for fat-reducing, blood fat reducing, blood sugar lowering, blood pressure lowering, the osteoporotic compound preparation of control |
| CN102188565A (en) * | 2011-04-09 | 2011-09-21 | 荣成百合生物技术有限公司 | Weight-losing soft capsules and preparation method thereof |
| CN102188565B (en) * | 2011-04-09 | 2012-05-30 | 荣成百合生物技术有限公司 | Weight-losing soft capsules and preparation method thereof |
| CN105663912A (en) * | 2015-12-30 | 2016-06-15 | 韩俊峰 | Compound traditional Chinese medicine pill for reducing weight |
| CN107625914A (en) * | 2017-10-16 | 2018-01-26 | 唐宏泉 | A kind of cosmetic slimming nutrition and health care capsule and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4699901B2 (en) | Dietary additive with body fat metabolism function and combustion energy utilization function | |
| DE102006062250A1 (en) | Use of a composition of minerals and / or vitamins and optionally acetogenic and / or butyrogenic bacteria for oral or rectal administration for the treatment and prevention of abdominal discomfort | |
| AU2020294253B2 (en) | Nutritional Composition For Promoting Intestinal Health | |
| CN106343218A (en) | Vitamin and amino acid nutritive liquid for pets and preparation method thereof | |
| CN101548731A (en) | Commercial pig green feed | |
| CN107821602A (en) | Nutrient formulation powder that a kind of suitable muscle decay crowd eats and preparation method thereof | |
| CN108391811A (en) | A kind of tumour full nutrition formula food and its application | |
| CN109329727A (en) | Antioxidant composition, anti-oxidation preparation and application | |
| CN1349795A (en) | Compound slimming prepn and its application | |
| JP2004321171A (en) | Food and drink | |
| CN103651949A (en) | Health-maintaining and weight-losing type blending oil | |
| CN106359849B (en) | A kind of fermented feed of the microelement containing humic acid chelating and preparation method thereof | |
| CN103315175B (en) | Biogas residue containing chicken formula feed | |
| CN101194681B (en) | Health care feedstuff for chickens | |
| CN104161226A (en) | Feed for preventing broilers from feed passage in summer | |
| Wang et al. | Effect of Chinese herbal medicines on rumen fermentation, methanogenesis and microbial flora in vitro | |
| CN107279532A (en) | A kind of piglet feed of composition, compound premix and gained for piglet feed | |
| JP6830976B2 (en) | MicroRNA expression enhancer and food and drink for microRNA expression enhancer | |
| CN107467193A (en) | Full nutrition special medicine purposes formula food of a kind of pulvis based on goat milk and preparation method thereof | |
| CN106721462A (en) | Chinese herbal feed additive for laying hen and preparation method and application | |
| CN102550847A (en) | Poultry feed including eleutheroside and composite probiotic and making method thereof | |
| JPS6049775A (en) | Production of nutrient food | |
| CN102845594A (en) | Novel low-cholesterol animal health product | |
| Lee | A flood of health functional foods: what is to be recommended? | |
| Hosseintabar et al. | Is the amount of l-carnitine and methionine-lysine affect on the microbial flora of broiler cecum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |